Nanovi
Lyngby
About Nanovi
Nanovi was founded in late 2010 with the aim of raising radiotherapy standards without compulsory changes in current routines and equipment. The idea arose from a real medical need for better guidance of radiation treatment of cancer patients that the founders believed could be solved by advanced biomaterials and drug-delivery technologies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $9.7M
- Last round: Series Unknown (Nov 2020)
- Website: nanovi.com
- Phone: [email protected]
Industries & Categories
Health Care, Life Science, Medical Device, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/nanovi-135423 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.